Partner
Matthew Hlinka has experience across all areas of patent and trade secret law, focusing primarily on litigation in the areas of pharmaceuticals and chemical products. He has successfully represented several branded pharmaceutical companies in Abbreviated New Drug Application (ANDA) litigations arising under the Hatch-Waxman Act in U.S. district courts as well as in international arbitration proceedings, in Section 337 proceedings before the International Trade Commission (ITC), and in post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).
Matthew’s litigation experience spans all phases of federal district court and ITC litigation as well as international arbitration, from pre-suit investigations through trial and post-trial briefing. His responsibilities include developing and preparing detailed contentions, managing complex discovery, taking and defending fact and expert depositions, working with expert witnesses to prepare expert reports, drafting briefs and motions, and conducting direct and cross examinations of witnesses at trial. Matthew is an experienced manager of litigation teams and day-to-day litigation activities.
Matthew’s practice includes patent prosecution and client counseling. He handles preparing and prosecuting U.S. patent applications, coordinating foreign prosecution, developing patent portfolio strategies, preparing opinions on patent infringement and validity, and drafting license agreements.
Prior to his legal career, Matthew worked as an instrumentation engineer for Ambitech Engineering in Downers Grove, Illinois. He provided on-site construction field support and assisted with the specification and procurement of instrumentation for a new polysilicate production plant.
Matthew has been repeatedly recognized by the D.C. Bar’s Capital Pro Bono Honor Roll for his advocacy on behalf of disabled veterans before the U.S. Court of Appeals for Veterans Claims.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Trial counsel for Novartis in district court litigation against multiple generics related to KISQALI®, a breakthrough CDK4/6-inhibitor for the treatment of breast cancer.
1:21-cv-00870, D. Del., Judge Hall
AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
Trial counsel for AstraZeneca in Abbreviated New Drug Application (ANDA) litigation against Zydus on its blockbuster Farxiga® pharmaceutical drug product. After a bench trial, Judge Andrews ruled that the defendant failed to prove that any of the patent claims at issue were invalid due to obviousness, resulting in a complete win for our client. That decision was not ultimately appealed.
1:18-cv-00664, D. Del., Judge Andrews
CMC Materials, LLC v. Dupont de Nemours, Inc. et al.
1:20-cv-00738, D. Del., Judge Hall
Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.
2:16-cv-00217; 2:17-cv-00544, -01568, D.N.J., Judges Chesler, Waldor
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
3:17-cv-00449, D.N.J., Judges Sheridan, Goodman
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
2:15-cv-08180, 2:17-cv-06714, D.N.J., Judges Chesler, Waldor
Webinar
What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners What’s Working at the PTAB Now: Strategies for Petitioners and Patent Owners
March 4, 2026
Webinar
Webinar
Protect Your Innovations: Recent Patent Case Law in the Life Sciences Protect Your Innovations: Recent Patent Case Law in the Life Sciences
February 11, 2026
Webinar
Webinar
Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents
February 18, 2025
Webinar
Webinar
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
January 9, 2025
Webinar
Webinar
Recent Court Decisions in the Life Sciences Recent Court Decisions in the Life Sciences
May 22, 2024
Webinar
Webinar
Recent IPR and District Court Litigation in the Life Sciences Recent IPR and District Court Litigation in the Life Sciences
July 12, 2023
Webinar
Award/Ranking
Best Lawyers Recognizes 44 Finnegan Attorneys in its 2026 Edition of The Best Lawyers and Ones to Watch Best Lawyers Recognizes 44 Finnegan Attorneys in its 2026 Edition of The Best Lawyers and Ones to Watch
August 21, 2025
Best LawyersPress Release
Twelve Attorneys Elevated to Finnegan Partnership Twelve Attorneys Elevated to Finnegan Partnership
January 7, 2025
Media Mention
Litigators of the Week: Shout Out Litigators of the Week: Shout Out
October 22, 2021
The AmLaw Litigation DailyDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.